SMALL CELL LUNG CARCINOMA
Clinical trials for SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: CBX-12 drug trial begins
Disease control CompletedThis study tested a new drug called CBX-12 in 69 adults with advanced solid tumors (like ovarian, lung, or breast cancer) that had stopped responding to standard treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study was completed, but res…
Matched conditions: SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Liver health may change how lung cancer drug works
Knowledge-focused CompletedThis study looked at how different levels of liver function affect the way the body processes the drug JDQ443. Researchers gave a single dose to 33 people with small cell lung cancer who had mild, moderate, or severe liver problems, and compared them to healthy volunteers. The go…
Matched conditions: SMALL CELL LUNG CARCINOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC